C
AKRO

Covestor’s Akero Therapeutics AKRO Stock Holding History

Covestor’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed – – 2222
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2234
2025
Q2 		$0 Hold
4
– – ﹤0.01% 2154
2025
Q1 		$0 Hold
4
– – ﹤0.01% 2162
2024
Q4 		$0 Hold
4
– – ﹤0.01% 2183
2024
Q3 		$0 Hold
4
– – ﹤0.01% 2159
2024
Q2 		$0 Hold
4
– – ﹤0.01% 2190
2024
Q1 		$0 Sell
4
-5
-56% -$120 ﹤0.01% 2188
2023
Q4 		$0 Buy
9
+6
+200% +$118 ﹤0.01% 2090
2023
Q3 		$0 Hold
3
– – ﹤0.01% 2057
2023
Q2 		$0 Hold
3
– – ﹤0.01% 2076
2023
Q1 		$0 Hold
3
– – ﹤0.01% 1954
2022
Q4 		$0 Buy
+3
New +$129 ﹤0.01% 2000

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Covestor's AKRO Position: Q4 2025 in Review

Covestor sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4 shares.

Covestor first reported a position in AKRO in Q4 2022 and held it in 12 quarters. The position peaked at $0 in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Covestor reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Covestor sold 4 Akero Therapeutics shares in Q4 2025.
  • Covestor first reported a position in Akero Therapeutics in Q4 2022 and held it in 12 quarters.
  • Covestor's Akero Therapeutics position peaked at $0 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Covestor's 13F filing for Q4 2025, filed 6 Feb 2026.